Terms: = Endocrine gland cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Treatment
22 results:
1. The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
Nie X; Xu T; Zhang L; Cheng W
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():97-104. PubMed ID: 38219610
[TBL] [Abstract] [Full Text] [Related]
2. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic cancer.
Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
[TBL] [Abstract] [Full Text] [Related]
3. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic cancer: A Randomized Clinical Trial.
Conroy T; Castan F; Lopez A; Turpin A; Ben Abdelghani M; Wei AC; Mitry E; Biagi JJ; Evesque L; Artru P; Lecomte T; Assenat E; Bauguion L; Ychou M; Bouché O; Monard L; Lambert A; Hammel P;
JAMA Oncol; 2022 Nov; 8(11):1571-1578. PubMed ID: 36048453
[TBL] [Abstract] [Full Text] [Related]
4. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.
Shi Z; Ma C; Huang X; Cao D
J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
[TBL] [Abstract] [Full Text] [Related]
5. Day of surgery and mortality after pancreatoduodenectomy: A retrospective analysis of 29 270 surgical cases of pancreatic head cancer from Japan.
Uemura S; Endo H; Ichihara N; Miyata H; Maeda H; Hasegawa H; Kamiya K; Kakeji Y; Yoshida K; Yasuyuki S; Yamaue H; Yamamoto M; Kitagawa Y; Hanazaki K
J Hepatobiliary Pancreat Sci; 2022 Jul; 29(7):778-784. PubMed ID: 34496150
[TBL] [Abstract] [Full Text] [Related]
6. Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer.
Yao F; Ding J; Hu Z; Cai M; Liu J; Huang X; Zheng R; Lin F; Lan L
Abdom Radiol (NY); 2021 Oct; 46(10):4936-4945. PubMed ID: 34120235
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors for incomplete response in thyroid microcarcinoma: an analysis of initial response to therapy in 517 patients.
Faro FN; Simões VRF; Ricardo GP; Cabral CP; de Cássia Braga Ribeiro K; Scalissi NM; Cury AN; Marone MM; do Prado Padovani R; Ferraz C
Arch Endocrinol Metab; 2021 Oct; 65(5):579-587. PubMed ID: 33740337
[TBL] [Abstract] [Full Text] [Related]
8. [A comparative study on the efficacy of transoral vestibular approach, via bilateral areola approach endoscopic and open thyroidectomy on stage T1b papillary thyroid carcinoma].
Liu ZD; Li YJ; Yu X; Xiang C; Wang P; Wang Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Oct; 55(10):905-912. PubMed ID: 33036504
[No Abstract] [Full Text] [Related]
9. Early Diagnosis of Medullary Thyroid cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
10. Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study.
Choi HJ; Lee YY; Sohn I; Kim YM; Kim JW; Kang S; Kim BG
Curr Probl Cancer; 2020 Apr; 44(2):100508. PubMed ID: 31708114
[TBL] [Abstract] [Full Text] [Related]
11. The Transareola Endoscopic Approach Yields Adequate Oncological Dissection as Open Approach in the treatment of Papillary Thyroid Carcinoma.
Gao H; Chen C; Liu X; Xu N; Wang Y; Qu R; Yu X
Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):489-492. PubMed ID: 31584497
[TBL] [Abstract] [Full Text] [Related]
12. Niraparib Maintenance Therapy in Patients With Recurrent Ovarian cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Del Campo JM; Matulonis UA; Malander S; Provencher D; Mahner S; Follana P; Waters J; Berek JS; Woie K; Oza AM; Canzler U; Gil-Martin M; Lesoin A; Monk BJ; Lund B; Gilbert L; Wenham RM; Benigno B; Arora S; Hazard SJ; Mirza MR
J Clin Oncol; 2019 Nov; 37(32):2968-2973. PubMed ID: 31173551
[TBL] [Abstract] [Full Text] [Related]
13. Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy.
Hua YQ; Wang P; Zhu XY; Shen YH; Wang K; Shi WD; Lin JH; Meng ZQ; Chen Z; Chen H
Pancreatology; 2017; 17(6):967-973. PubMed ID: 29129384
[TBL] [Abstract] [Full Text] [Related]
14. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract] [Full Text] [Related]
15. [Complications after therapeutic dissection of the neck in the treatment of differentiated thyroid gland cancer].
Palamarchuk VA
Klin Khir; 2014 Jan; (1):28-31. PubMed ID: 24923146
[TBL] [Abstract] [Full Text] [Related]
16. The incidence and survival rate of population-based pancreatic cancer patients: Shanghai cancer Registry 2004-2009.
Luo J; Xiao L; Wu C; Zheng Y; Zhao N
PLoS One; 2013; 8(10):e76052. PubMed ID: 24130758
[TBL] [Abstract] [Full Text] [Related]
17. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.
Boyd CA; Benarroch-Gampel J; Sheffield KM; Han Y; Kuo YF; Riall TS
Surgery; 2012 Sep; 152(3):403-13. PubMed ID: 22938900
[TBL] [Abstract] [Full Text] [Related]
18. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.
Zetoune T; Keutgen X; Buitrago D; Aldailami H; Shao H; Mazumdar M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2010 Dec; 17(12):3287-93. PubMed ID: 20596784
[TBL] [Abstract] [Full Text] [Related]
19. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
[TBL] [Abstract] [Full Text] [Related]
20. A phase II study of weekly 24-h infusion of high-dose 5-fluorouracil in advanced pancreatic cancer.
Lutz MP; Königer M; Muche R; Ellenrieder V; Steinkamp M; Adler G; Gress TM
Z Gastroenterol; 1999 Oct; 37(10):993-7. PubMed ID: 10549093
[TBL] [Abstract] [Full Text] [Related]
[Next]
